A pilot study to evaluate the efficacy and safety of different bindarit dosages in preventing stent restenosis.

Trial Profile

A pilot study to evaluate the efficacy and safety of different bindarit dosages in preventing stent restenosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs Bindarit (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia; Unstable angina pectoris
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2012 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
    • 07 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Apr 2012 This trial has been completed in Italy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top